Intra-arterial infusion chemotherapy utilizing cisplatin inhibits bladder cancer by decreasing the fibrocytic myeloid-derived suppressor cells in an m6A-dependent manner-MedSci.cn

Intra-arterial infusion chemotherapy utilizing cisplatin inhibits bladder cancer by decreasing the fibrocytic myeloid-derived suppressor cells in an m6A-dependent manner

Mu, XY; Wu, K; Zhu, YW; Zhu, YJ; Wang, Y; Xiao, L; Yao, ZX; Huang, WJ; Sun, F; Fan, J; Zheng, Z; Liu, ZH

Zheng, Z; Liu, ZH (corresponding author), Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Sch Med, Dept Urol, Haining Rd 100, Shanghai 200080, Peoples R China.

MOLECULAR IMMUNOLOGY, 2021; 137 (): 28

Abstract

Intra-arterial infusion chemotherapy (IAIC), using immunomodulatory cisplatin, is a novel treatment for bladder cancer (BC) that allows the delivery o......

Full Text Link